Michael Stubblefield Net Worth

The estimated Net Worth of Michael Stubblefield is at least $23 Million dollars as of 5 August 2023. Mr. Stubblefield owns over 1,857 units of Avantor stock worth over $49,972 and over the last 5 years he sold AVTR stock worth over $5,986,881. In addition, he makes $16,995,300 as President, Chief Executive Officer, and Director at Avantor.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Stubblefield AVTR stock SEC Form 4 insiders trading

Michael has made over 6 trades of the Avantor stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 1,857 units of AVTR stock worth $49,972 on 5 August 2023.

The largest trade he's ever made was exercising 1,090,970 units of Avantor stock on 4 December 2020 worth over $1,745,552. On average, Michael trades about 74,493 units every 48 days since 2020. As of 5 August 2023 he still owns at least 1,857 units of Avantor stock.

You can see the complete history of Mr. Stubblefield stock trades at the bottom of the page.

Michael Stubblefield biography

Michael Stubblefield serves as President, Chief Executive Officer, Director of the Company. Mr. Stubblefield became our President and Chief Executive Officer in 2014. In addition, Mr. Stubblefield also serves as a Director. Prior to joining us, Mr. Stubblefield was a Senior Expert for the Chemicals Practice of McKinsey & Company, a management consulting firm, from 2013 to 2014. Previously, he held a variety of leadership roles at Celanese Corporation, a technology and specialty materials company, from 1994 to 2012. Mr. Stubblefield holds a B.S. in Chemical Engineering from the University of Utah, as well as an M.B.A. from Texas A&M University-Corpus Christi. Mr. Stubblefield’s leadership role and extensive knowledge of our business, strategy and industry on an international basis make him a valuable member of our Board.

What is the salary of Michael Stubblefield?

As the President, Chief Executive Officer, and Director of Avantor, the total compensation of Michael Stubblefield at Avantor is $16,995,300. There are no executives at Avantor getting paid more.

How old is Michael Stubblefield?

Michael Stubblefield is 47, he's been the President, Chief Executive Officer, and Director of Avantor since . There are 26 older and 5 younger executives at Avantor. The oldest executive at Avantor Inc. is Rajiv Gupta, 74, who is the Chairman of the Board.

What's Michael Stubblefield's mailing address?

Michael's mailing address filed with the SEC is RADNOR CORPORATE CENTER, BUILDING ONE,, SUITE 200, 100 MATSONFORD ROAD, RADNOR, PA, 19087.

Insiders trading at Avantor

Over the last 5 years, insiders at Avantor have traded over $3,149,576,044 worth of Avantor stock and bought 27,800 units worth $584,024 . The most active insiders traders include Mountain Investments Iii, L..., Jo Natauri, and Sachs & Co. Llc Stone Bridg.... On average, Avantor executives and independent directors trade stock every 21 days with the average trade being worth of $48,107,115. The most recent stock trade was executed by Steven W Eck on 5 September 2024, trading 3,525 units of AVTR stock currently worth $88,337.

What does Avantor do?

based in center valley, pa (usa), avantor performance materials manufactures and markets high-performance chemistries and materials around the world under several respected brand names, including the j.t.baker®, macron fine chemicals™, rankem™, benesphera™, and poch™ brands. avantor products are used in a wide range of industries. our life sciences solutions are used in pharmaceutical production, laboratory research for academic, industry and quality control, and in medical lab testing. our electronics solutions are used in the manufacturing of semiconductors. for additional information please visit www.avantormaterials.com

Complete history of Mr. Stubblefield stock trades at Avantor and Ingersoll Rand

Avantor executives and stock owners

Avantor executives and other stock owners filed with the SEC include:

• Michael Stubblefield,
  President, Chief Executive Officer, Director
• Thomas Szlosek,
  Chief Financial Officer, Executive Vice President
• Michael Stubblefield,
  Pres, CEO & Director
• Gerard Brophy,
  Executive Vice President - Biopharma Production
• Devashish Ohri,
  Executive Vice President - AMEA
• Frederic Vanderhaegen,
  Executive Vice President - Americas and Europe
• Thomas A. Szlosek,
  Exec. VP & CFO
• Frederic Vanderhaegen,
  Exec. VP of Americas & Europe
• Dr. Gerald Brophy Ph.D.,
  Exec. VP of Biopharma Production
• Michael Wondrasch,
  Exec. VP & Chief Information Officer
• Rajiv Gupta,
  Chairman of the Board
• Jonathan Peacock,
  Independent Director
• Christi Shaw,
  Independent Director
• Rakesh Sachdev,
  Independent Director
• Juan Andres,
  Independent Director
• Gregory Summe,
  Independent Director
• Michael Severino,
  Independent Director
• Jo Natauri,
  Director
• Andre Moura,
  Director
• Matthew Holt,
  Director
• Steven Eck,
  Senior Vice President, Chief Accounting Officer
• Mark Murray,
  Executive Vice President of the Biomaterials and Advanced Technologies Platform
• Sven Henrichwark,
  Executive Vice President of APAC
• Tanya Foxe,
  Executive Vice President - Global Operations and Supply Chain
• Christophe Couturier,
  Executive Vice President - Services, Strategy and Business Transformation
• James Bramwell,
  Executive Vice President - Strategic Partners
• Justin Miller,
  Executive Vice President, General Counsel, Secretary
• Michael Wondrasch,
  Executive Vice President, Chief Information Officer
• Eric McAllister,
  Chief Human Resource Officer, Executive Vice President
• Allison K. Hosak,
  Sr. VP of Global Communications & Brand
• Justin M. Miller Esq.,
  Exec. VP, Gen. Counsel & Sec.
• Tommy J. Thomas CPA,
  VP of Investor Relations
• Steven W. Eck,
  Sr. VP, Corp. Controller & Chief Accounting Officer
• Sheri Lewis,
  Exec. VP, Global Operations & Supply Chain
• Lan Kang,
  Director
• John Carethers,
  Director
• Sachs & Co. Llc Stone Bridg...,
  
• Sachs & Co. Llc Stone Bridg...,
  
• Sheri Lewis,
  EVP, Global Ops & Supply Chain
• Mountain Investments Iii, L...,
  
• Mala Murthy,
  Director
• Brittany Hankamer,
  EVP, Chief HR Officer
• Randy Lee Stone,
  EVP, Laboratory Solutions
• Corey Walker,
  President Laboratory Solutions
• Ashish Kulkarni,
  See Remarks
• Sachs & Co. Llcgoldman Sach...,
  
• Meghan Henson,
  EVP, Chief HR Officer
• Thomas Connolly,
  Director
• Joseph R Massaro,
  Director
• Kitty Sahin,
  EVP, Strategy&Corp Development
• Claudius Sokenu,
  EVP, Chief Legal & Compliance
• R. Brent Jones,
  EVP, Chief Financial Officer
• Benoit Gourdier,
  EVP, Biopharma Production